CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson

Research To Practice | Oncology Videos · Apr 11, 2026 · 24m

Featuring perspectives from Dr Paul G Richardson, including the following topics:

EXCALIBER-RRMM: A Phase III trial of iberdomide, daratumumab and dexamethasone for relapsed/refractory multiple myeloma (0:00)

Lonial S et al. EXCALIBER-RRMM: A phase III trial of iberdomide, daratumumab, and dexamethasone in relapsed/refractory multiple myeloma. Future Oncol 2025;21(14):1761-9. Abstract

Phase III SUCCESSOR-1 and SUCCESSOR-2 studies evaluating mezigdomide-based regimens for relapsed/refractory multiple myeloma (8:24)

Richardson PG et al. A phase III, two-stage, randomized study of mezigdomide…